Perimenopause — the 4-10 years leading up to menopause, typically starting in the mid-40s — is characterized by erratic, progressively declining ovarian estradiol production. That biological shift produces several predictable skin changes.
Dryness. Estradiol supports the moisture-retaining function of the epidermis and stratum corneum. As estradiol drops, transepidermal water loss increases and sebum production shifts, producing a dry-skin pattern that many women experience for the first time in adulthood (Rzepecki, 2019).
Cyclical adult acne. As estrogen falls relative to unchanged androgens, the ratio shifts. Sebum production increases and adult acne — usually on the jawline and chin — appears or worsens. Often paired with more visible pores (Zeichner, 2017).
Thinning skin and reduced elasticity. Dermal collagen synthesis begins to decline even before menopause proper. Skin thins, feels less resilient, and may show earlier fine lines. The Brincat 1983 data established this trajectory (Brincat, 1983).
Increased sensitivity. Barrier function is estrogen-dependent, and as it weakens, skin becomes more reactive to products, weather, and stress.
Slower wound healing. Estrogen supports repair; healing slows measurably through perimenopause.
Increased inflammatory tone. Perimenopause is associated with modest increases in inflammaging markers, which compound the changes above (Franceschi, 2000).
What to measure to see where you are: estradiol, hs-CRP, fasting insulin. The JenSkin panel measures all three as part of the standard nine.